UAB "TBS Pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
1,639,364 |
255,751 |
138,517 |
123,067 |
19,199 |
20.81 |
7.51 |
153,704 |
431,224 |
21,054 |
563,874 |
2023 |
---|
1,758,954 |
293,159 |
138,775 |
117,536 |
19,589 |
18.76 |
6.68 |
271,240 |
547,237 |
15,124 |
803,353 |
2024 |
---|
1,589,674 |
293,298 |
94,243 |
80,065 |
14,772 |
18.79 |
5.04 |
351,305 |
650,120 |
9,983 |
991,442 |
Register and
explore Okredo dataRegister and
explore Okredo data2024
Turnover (€)
1,589,674 €-10 % *
Sales per employee (€)
293,298 €0 % *
Profit before tax (€)
94,243 €-32 % *
Net Profit (€)
80,065 €-32 % *
Profit per employee (€)
14,772 €-25 % *
Total profitability (%)
18.79 %0.16 % *
Net profitability (%)
5.04 %-24.55 % *
Equity (€)
351,305 €30 % *
Amounts Payable And Liabilities (€)
650,120 €19 % *
Non-current Assets (€)
9,983 €-34 % *
CurrentAssets (€)
991,442 €23 % *